Brief resolved unexplained event: Difference between revisions

No edit summary
Line 3: Line 3:
*ALTE is a symptom, not a dx
*ALTE is a symptom, not a dx
*Only 10% have repeat events
*Only 10% have repeat events
*ALTE is not related to SIDS
*ALTE is not related to [[SIDS]]


== Diagnosis ==
=== Risk Factors ===
*Episode that is frightening to caregiver and involves combination of:
*RSV infection
**Apnea
*Prematurity
**Color change
*Recent anesthesia
**Muscle tone change
*GERD
**Choking or gagging
*Airway/maxillofacial anomalies
*Age < 10 wks
*Hx of apneas
*Pallor, cyanosis, feeding difficulties
 
== Clinical Features ==
Episode that is frightening to caregiver and involves combination of:
*Apnea
*Color change
*Muscle tone change
*Choking or gagging


==History==
==History==
Line 27: Line 37:
**Medication use
**Medication use


== Risk Factors ==
== Differential Diagnosis<ref>McGovern MC. et al. Smith MB. Causes of apparent life threatening events in children: a systemic review. Arch Dis Child. 2004;89(11):1043-1048</ref> ==
#RSV infection
#Prematurity
#Recent anesthesia
#GERD
#Airway/maxillofacial anomalies
#Age < 10 wks
#Hx of apneas
#Pallor, cyanosis, feeding difficulties
 
== DDX<ref>McGovern MC. et al. Smith MB. Causes of apparent life threatening events in children: a systemic review. Arch Dis Child. 2004;89(11):1043-1048</ref> ==
===Common<ref>Okada K et al. Discharge Diagnoses in infants with apparent life threatening event admissions and gastroesophageal reflux disease. Pediatric Emergency Care. 2012;28(1):17-21</ref>===
===Common<ref>Okada K et al. Discharge Diagnoses in infants with apparent life threatening event admissions and gastroesophageal reflux disease. Pediatric Emergency Care. 2012;28(1):17-21</ref>===
#Idiopathic (~50%)
*Idiopathic (~50%)
#GERD
*GERD
#Seizure
*Seizure
#Respiratory tract infection
*Respiratory tract infection
#Misinterpretation of benign process (e.g. periodic breathing)
*Misinterpretation of benign process (e.g. periodic breathing)
#Vomiting/choking episode
*Vomiting/choking episode


===Less Common===
===Less Common===
#Pertussis
*Pertussis
#Inflicted injury
*Inflicted injury
#Poisoning
*Poisoning
#Serious bacterial infection
*Serious bacterial infection
##Must consider in all febrile pts with ALTE
**Must consider in all febrile pts with ALTE
#Electrolyte abnormality (incl glucose)
*Electrolyte abnormality (incl glucose)


===Uncommon===
===Uncommon===
#Arrhythmia
*Arrhythmia
#[[Anemia]]
*[[Anemia]]
#Breath-holding spell (6mo - 4yrs)
*Breath-holding spell (6mo - 4yrs)
#Metabolic disease
*Metabolic disease


== Work-Up ==
== Work-Up ==
(Individualize testing by history and exam)
(Individualize testing by history and exam)


#CBC
*CBC
#Chem 10
*Chem 10
#UA  
*UA  
#CXR  
*CXR  
#Pertussis nasal swab  
*Pertussis nasal swab  
#RSV nasal swab  
*RSV nasal swab  
#Consider:
*Consider:
##UCx/BC
**UCx/BC
##ECG  
**ECG  
##LP  
**LP  
##LFTs
**LFTs
##MRI Brain
**MRI Brain


== Management ==
== Management ==
#Stable patients without a clear diagnosis
*Stable patients without a clear diagnosis
##No evidence-based guidelines for proper w/u dispo decision
**No evidence-based guidelines for proper w/u dispo decision
#Stable patients with a clear diagnosis
*Stable patients with a clear diagnosis
##Manage according to identified disease
**Manage according to identified disease




===Empiric Treatment for Unstable Patients===
===Empiric Treatment for Unstable Patients===
{| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%"
{| cellspacing="1" cellpadding="3" border="0" bgcolor="*666666" width="100%"
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Medication/Intervention
! valign="top" bgcolor="*ffffff" align="left" rowspan="0" | Medication/Intervention
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Indication
! valign="top" bgcolor="*ffffff" align="left" rowspan="0" | Indication
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Dose/Size (for neonate)
! valign="top" bgcolor="*ffffff" align="left" rowspan="0" | Dose/Size (for neonate)
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Glucose
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Glucose
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypoglycemia
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypoglycemia
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 5–10 mL/kg of 10% dextrose in water IV
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 5–10 mL/kg of 10% dextrose in water IV
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 3% normal saline
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 3% normal saline
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Symptomatic hyponatremia
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Symptomatic hyponatremia
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 3–5 mL/kg bolus IV
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 3–5 mL/kg bolus IV
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Calcium
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Calcium
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypocalcemia
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypocalcemia
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50–100 milligrams/kg calcium gluconate or 20 milligrams/kg calcium chloride IV
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50–100 milligrams/kg calcium gluconate or 20 milligrams/kg calcium chloride IV
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Cefotaxime
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Cefotaxime
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Infection
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Infection
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50 milligrams/kg IV
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50 milligrams/kg IV
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Ampicillin
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Ampicillin
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Infection
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Infection
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50 milligrams/kg IV
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 50 milligrams/kg IV
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Packed red blood cells
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Packed red blood cells
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Anemia
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Anemia
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 10 mL/kg IV
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 10 mL/kg IV
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Normal saline
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Normal saline
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypotension, dehydration
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypotension, dehydration
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 20 mL/kg IV
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 20 mL/kg IV
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 10% dextrose in one fourth normal saline
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 10% dextrose in one fourth normal saline
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Metabolic disease
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Metabolic disease
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 1.5 maintenance (6 mL/kg/h for the first 10 kg)
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 1.5 maintenance (6 mL/kg/h for the first 10 kg)
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Endotracheal intubation
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Endotracheal intubation
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypoventilation or frequent apnea
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Hypoventilation or frequent apnea
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | <span class="Apple-style-span" style="font-size: 12px; ">3mm&nbsp;for preemie; 3mm&nbsp;for term neonate, 4mm</span><span class="Apple-style-span" style="font-size: 10px;">&nbsp;</span>for older infant
| valign="top" bgcolor="*ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | <span class="Apple-style-span" style="font-size: 12px; ">3mm&nbsp;for preemie; 3mm&nbsp;for term neonate, 4mm</span><span class="Apple-style-span" style="font-size: 10px;">&nbsp;</span>for older infant
|}
|}


Line 131: Line 131:


Especially for:
Especially for:
#<48wk postconceptual age
*<48wk postconceptual age
#Ill-appearing
*Ill-appearing
#Bronchiolitis or pertussis w/ apnea
*Bronchiolitis or pertussis w/ apnea
#>1 event in past 24hr or multiple ALTEs
*>1 event in past 24hr or multiple ALTEs
#Abnormalities in PMH
*Abnormalities in PMH
#Prolonged central apnea >20s
*Prolonged central apnea >20s
#ALTE requiring resus
*ALTE requiring resus
#Family history of SIDS
*Family history of SIDS


==Current Research==
==Current Research==
Line 145: Line 145:
*300 Infants in a single center with 76% admission rate with 37 (12%) required significant intervention   
*300 Infants in a single center with 76% admission rate with 37 (12%) required significant intervention   
;Predictors for requiring intervention
;Predictors for requiring intervention
#Prematurity
*Prematurity
#Abnormal physical examination
*Abnormal physical examination
#Color change to cyanosis,
*Color change to cyanosis,
#Absence of upper respiratory infection symptoms and the absence of choking
*Absence of upper respiratory infection symptoms and the absence of choking
*Negative predictive value: 96%  
*Negative predictive value: 96%  
*Specificity of 70.5%  
*Specificity of 70.5%  
Line 156: Line 156:
*832 patients from 4 different study sites, with a 79.2% admission rate
*832 patients from 4 different study sites, with a 79.2% admission rate
;Predictors for requiring admission
;Predictors for requiring admission
#Obvious need for admission:
*Obvious need for admission:
##Supplemental Oxygen requirement
**Supplemental Oxygen requirement
##Resuscitation
**Resuscitation
##Hemodynamic Instability
**Hemodynamic Instability
##Positive RSV or Pertussis test
**Positive RSV or Pertussis test
#Significant past medical history
*Significant past medical history
##Congenital heart disease
**Congenital heart disease
##Down Syndrome
**Down Syndrome
##Previous Intubation
**Previous Intubation
#Chromosomal abnormaility
*Chromosomal abnormaility
#Chronic Lung Disease
*Chronic Lung Disease
# > 1 ALTE in 24 hours
* > 1 ALTE in 24 hours
*Negative predictive value of 96.5%  
*Negative predictive value of 96.5%  
*Sensitivity of 89% , a Specificity of 61.9% , and a calculated  
*Sensitivity of 89% , a Specificity of 61.9% , and a calculated  

Revision as of 11:37, 12 May 2015

Background

  • Peak incidence: 1wk - 2mo
  • ALTE is a symptom, not a dx
  • Only 10% have repeat events
  • ALTE is not related to SIDS

Risk Factors

  • RSV infection
  • Prematurity
  • Recent anesthesia
  • GERD
  • Airway/maxillofacial anomalies
  • Age < 10 wks
  • Hx of apneas
  • Pallor, cyanosis, feeding difficulties

Clinical Features

Episode that is frightening to caregiver and involves combination of:

  • Apnea
  • Color change
  • Muscle tone change
  • Choking or gagging

History

  • PMH
    • Prematurity, history of apnea, prior resp/feeding difficulties
    • Immunization status (pertussis)
  • FH
    • History of SIDS, cardiac, seizure, metabolic disease
  • Event
    • Duration, resus required
    • Temporal relationship with feeding, sleeping, crying, vomiting, choking
    • Central versus obstructive pattern of apnea
    • Episodic versus sustained change in mental status
  • ROS
    • Respiratory symptoms
    • Medication use

Differential Diagnosis[1]

Common[2]

  • Idiopathic (~50%)
  • GERD
  • Seizure
  • Respiratory tract infection
  • Misinterpretation of benign process (e.g. periodic breathing)
  • Vomiting/choking episode

Less Common

  • Pertussis
  • Inflicted injury
  • Poisoning
  • Serious bacterial infection
    • Must consider in all febrile pts with ALTE
  • Electrolyte abnormality (incl glucose)

Uncommon

  • Arrhythmia
  • Anemia
  • Breath-holding spell (6mo - 4yrs)
  • Metabolic disease

Work-Up

(Individualize testing by history and exam)

  • CBC
  • Chem 10
  • UA
  • CXR
  • Pertussis nasal swab
  • RSV nasal swab
  • Consider:
    • UCx/BC
    • ECG
    • LP
    • LFTs
    • MRI Brain

Management

  • Stable patients without a clear diagnosis
    • No evidence-based guidelines for proper w/u dispo decision
  • Stable patients with a clear diagnosis
    • Manage according to identified disease


Empiric Treatment for Unstable Patients

Medication/Intervention Indication Dose/Size (for neonate)
Glucose Hypoglycemia 5–10 mL/kg of 10% dextrose in water IV
3% normal saline Symptomatic hyponatremia 3–5 mL/kg bolus IV
Calcium Hypocalcemia 50–100 milligrams/kg calcium gluconate or 20 milligrams/kg calcium chloride IV
Cefotaxime Infection 50 milligrams/kg IV
Ampicillin Infection 50 milligrams/kg IV
Packed red blood cells Anemia 10 mL/kg IV
Normal saline Hypotension, dehydration 20 mL/kg IV
10% dextrose in one fourth normal saline Metabolic disease 1.5 maintenance (6 mL/kg/h for the first 10 kg)
Endotracheal intubation Hypoventilation or frequent apnea 3mm for preemie; 3mm for term neonate, 4mm for older infant

Disposition

Admission in most cases

Especially for:

  • <48wk postconceptual age
  • Ill-appearing
  • Bronchiolitis or pertussis w/ apnea
  • >1 event in past 24hr or multiple ALTEs
  • Abnormalities in PMH
  • Prolonged central apnea >20s
  • ALTE requiring resus
  • Family history of SIDS

Current Research

  • Neither of these decision rules have been validated

Mittal ALTE Decision Rule[3]

  • 300 Infants in a single center with 76% admission rate with 37 (12%) required significant intervention
Predictors for requiring intervention
  • Prematurity
  • Abnormal physical examination
  • Color change to cyanosis,
  • Absence of upper respiratory infection symptoms and the absence of choking
  • Negative predictive value: 96%
  • Specificity of 70.5%
  • 7 out of the 184 (3.8%) were incorrectly discharged

Kaji ALTE Decision Rule[4]

  • 832 patients from 4 different study sites, with a 79.2% admission rate
Predictors for requiring admission
  • Obvious need for admission:
    • Supplemental Oxygen requirement
    • Resuscitation
    • Hemodynamic Instability
    • Positive RSV or Pertussis test
  • Significant past medical history
    • Congenital heart disease
    • Down Syndrome
    • Previous Intubation
  • Chromosomal abnormaility
  • Chronic Lung Disease
  • > 1 ALTE in 24 hours
  • Negative predictive value of 96.5%
  • Sensitivity of 89% , a Specificity of 61.9% , and a calculated
  • 14 (2%) patients were incorrectly discharged

Sources

  • Fu L. et al. Apparent Life-threatening events: an update. Pediatr Rev. 2012; 33(8(:361-368
  • Tieder J et al. Management of apparent life-threatening events: a systemic review. J Pediatr. 2013 Jul;163(1):94-9
  1. McGovern MC. et al. Smith MB. Causes of apparent life threatening events in children: a systemic review. Arch Dis Child. 2004;89(11):1043-1048
  2. Okada K et al. Discharge Diagnoses in infants with apparent life threatening event admissions and gastroesophageal reflux disease. Pediatric Emergency Care. 2012;28(1):17-21
  3. Mittal M. et al. A clinical decision rule to identify infants with apparent life-threatening events who can be safely discharged from the emergency department. Pediatric Emergency Care. 2012;28(7): 599-605
  4. Kaji A et al. Apparent life-threatening event: multicenter prospective cohort study to develop a clinical decision rule for admission to the hospital. Ann Emerg Med. 2013;61(4):379-387